Zobrazeno 1 - 10
of 29
pro vyhledávání: '"S O MAZURENKO"'
Publikováno v:
Терапевтический архив, Vol 82, Iss 6, Pp 39-43 (2010)
Aim: to evaluate the effect of TaqI genotypes of vitamin D receptor (VDR) gene polymorphism on bone mineral density (BMD) and the risk for secondary osteoporosis (OP) in patients on programmed hemodialysis. Subjects and methods. Eighty-two patients t
Externí odkaz:
https://doaj.org/article/c59ceebaa6714088940707692fa303d5
Publikováno v:
Остеопороз и остеопатии, Vol 19, Iss 2, Pp 73-73 (2016)
Снижение минеральной плотности костной ткани отмечается при многих хронических заболеваниях, включая инфекционные, и, обычно, является
Externí odkaz:
https://doaj.org/article/479f593d86f04b3bb2b1bbdcf77ae24f
Publikováno v:
Остеопороз и остеопатии, Vol 19, Iss 2, Pp 37-37 (2016)
Цель. Изучить влияние полиморфизма эстрогеновых рецепторов α (ЭР-α) на показатели минеральной плотности костей (МПК) и риск переломов бо
Externí odkaz:
https://doaj.org/article/7ffe16b47d234d3a81def90aee104f21
Autor:
A. K. Gruzmanov, S. O. Mazurenko
Publikováno v:
Juvenis Scientia, Vol 8, Iss 6, Pp 15-29 (2022)
Sneddon syndrome is a rare, progressive disease that affects relatively young people, mainly female, and manifests itself in two main symptoms: livedo reticularis and recurrent cerebral infarctions. First described in 1965 by the English dermatologis
Externí odkaz:
https://doaj.org/article/10849643536b408697f2d4d85ba7859a
Autor:
Yu. M. Gomon, A. R. Kasimova, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov, S. O. Mazurenko
Publikováno v:
Безопасность и риск фармакотерапии, Vol 10, Iss 3, Pp 283-292 (2022)
Most of the medicines used to treat the novel coronavirus infection (COVID-19) are either approved under an accelerated procedure or not approved for the indication. Consequently, their safety requires special attention.The aim of the study was to re
Externí odkaz:
https://doaj.org/article/415405402b884605b93bdb4dcf047e8c
Publikováno v:
Атеротромбоз, Vol 11, Iss 2, Pp 103-120 (2022)
As established today by a number of studies, transferred COVID-19 (even mild) is associated with a high risk of delayed heart damage. Although human coronaviruses are a minor cause of all cases of viral myocarditis, they have been associated with myo
Externí odkaz:
https://doaj.org/article/6ba1fea4761649a494fb06caa2c25d0b
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 88-95 (2021)
Currently pulmonary embolism (PE) is already on the 3rd place in terms of the frequency of occurrence among vascular diseases, and there is a global trend towards an increase in its frequency. PE is also considered as the most common cause of prevent
Externí odkaz:
https://doaj.org/article/ca436a6fdf994b138301d06cf3f17170
Publikováno v:
Meditsinskiy sovet = Medical Council. :28-34
Introduction. Pulmonary embolism (PE) is one of the leading causes of death even in hospitalized patients. The standard treatment results are disappointing. Since 2004, we have tested a new method for the treatment of hemodynamically insignificant PE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c15ef3775f38a0c520f5a2cdca5c2f21
https://doi.org/10.21518/ms2022-048
https://doi.org/10.21518/ms2022-048
Autor:
I. A. Tuchin, S. O. Mazurenko, N. T. Mirzoev, G. G. Kutelev, N. V. Golovkin, S. A. Parfenov, P. V. Petrova, A. I. Tuchina
Publikováno v:
Marine Medicine. 9:39-45
OBJECTIVE: Assess the connection between clinical, laboratory and radiological manifestations of the new coronavirus infection.MATERIALS AND METHODS: The study conducted a retrospective analysis of 100 patient medical histories, treated in Saint Pete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5e3b664b5619f5633d844ca811585a7
https://doi.org/10.22328/2413-5747-2023-9-1-39-45
https://doi.org/10.22328/2413-5747-2023-9-1-39-45
Autor:
S. O. Mazurenko, Ya. A. Nakatis, O. G. Mazurenko, A. N. Vasilyev, A. A. Enkin, K. G. Staroselsky, N. A. Samokhvalova, T. S. Semenova, A. K. Grusmanov
Publikováno v:
Nephrology (Saint-Petersburg). 27:69-77
BACKGROUND. Chronic kidney disease leads to increased bone fragility and fractures. Assessing the risk of fractures is a direct way to prevent them. THE AIM: to assess the possibility of using DXA to predict fracture risk in patients with stage 5D CK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7eea63422235dc4fb383e2e34b7235bc
https://doi.org/10.36485/1561-6274-2023-27-1-69-77
https://doi.org/10.36485/1561-6274-2023-27-1-69-77